Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative botulinum toxin A for abdominal wall hernia repair
jRCTs041230054Completed
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in abdominal hernia. Primary endpoint: Recurrence rate at 1 year. Started Jun 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
abdominal hernia
Beyond the preview
Go deeper on jRCTs041230054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041230054.